PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6309518

Developmental changes in poly(A) polymerase activity in Artemia.

L Sastre·J Sebastián
View original source ↗Export metadata ↓

Abstract

The levels of poly(A) polymerase activity have been determined during Artemia early development. Poly(A) polymerase activity increases steadily during postgastrular embryonic development reaching a maximum shortly after hatching. The rise of poly(A) polymerase is concomitant with an increase in poly(A) content and with a change in the subcellular distribution of the enzyme activity, the major increase corresponding to the nuclear fraction. Only one isoenzyme of poly(A) polymerase has been identified in Artemia embryos and nauplii despite changes in enzyme levels and subcellular changes during early development. Poly(A) polymerase is not associated with the cytoplasmic poly(A)-containing ribonucleoprotein particles stored in Artemia dormant embryos.

Explore related subjects

ArtemiaCell NucleusCytosolIsoenzymesNucleotidyltransferasesPoly APolynucleotide AdenylyltransferaseRibonucleoproteinsComparative StudyJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L Sastre, J Sebastián. 1983-09-01. Developmental changes in poly(A) polymerase activity in Artemia.. https://doi.org/10.1111/j.1432-1033.1983.tb07618.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1987

Human elongation factor 1 alpha: a polymorphic and conserved multigene family with multiple chromosomal localizations.

One of the genes activated in human melanoma cells by the tumor-promoting phorbol ester is that of the elongation factor 1 alpha. A cDNA clone containing the complete 3'-end untranslated region and the nucleotide sequences coding for 227 carboxyterminal amino acids was isolated. Computer-assisted comparison with known sequences of elongation factors from other species revealed homologies up to 73% and 63% on amino acid and nucleotide sequences, respectively. Northern blot analysis of mRNA from unstimulated and phorbol ester-treated cells showed a 3- to 5-fold increase in cytoplasmic elongation factor 1 alpha mRNA after phorbol ester induction. When compared with the phorbol ester-inducible single-copy gene transcripts coding for the tissue-type plasminogen activator, the cellular mRNA content of elongation factor 1 alpha is 30 times higher. By Southern blot analysis experiments on human genomic DNA, a multi-gene family was found showing polymorphisms in restriction endonuclease fragment lengths (RFLP). Several polymorphisms were studied more extensively in the population on more than 100 DNA samples from normal individuals and in three-generation families. In situ hybridization of the cDNA probe to normal human metaphase chromosomes showed multiple chromosomal localizations of the elongation factor gene(s), with peak hybridization on the chromosomes 1, 2, 4, 5, 6, 7, and 15. The estimate of the gene copy number in humans is more than ten copies per (haploid) genome.

Artemia↗
PubMed1984

Inhibition of endoribonuclease VI from Artemia larvae by cytidine 2'-phosphate.

The endoribonuclease VI from Artemia larvae is non-competitively inhibited by cytidine 2'-phosphate with a Ki ca 1 microM. Neither of the cytidine monophosphates isomers with the phosphate group in the 3' or 5' position nor the cyclic 2':3' phosphate are inhibitors at concentrations up to 100 microM. Adenosine, guanosine and uridine 2' or 3' phosphates are also ineffective in this range of concentrations. Certain polyribonucleotides are potent competitive inhibitors of the ribonuclease activity.

Artemia↗